Please Enable Cookies to Continue
Please enable cookies in your browser to experience all the personalized features of this site, including the ability to apply for a job.
Welcome to our careers page!
Please click on the job title for more information, and apply from that page if you are interested.
Karyopharm Therapeutics Inc. (the "Company") is an equal opportunity employer. All qualified applicants will be considered without regard to age, race, color, sex, religion/creed, national origin, marital status, ancestry, citizenship, military, reservist or veteran status, pregnancy, sexual orientation or preference, gender identity, gender expression, physical or mental disability, genetic predisposition or carrier status, or any other category protected under applicable federal, state or local law. Consistent with its obligations under applicable law, the Company will make reasonable accommodations for qualified individuals with disabilities. If you require an accommodation in the application process, please contact a member of the Company’s Human Resources department.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
The system cannot access your location for 1 of 2 reasons:
- Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
- Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort
-
The Regulatory Science Lead is responsible for advancing and applying regulatory science to all our regulatory deliverables. The incumbent will leverage his/her scientific acumen and understanding of regulatory requirements to support the Regulatory Leads and partner with cross-functional Subject Matter Experts to optimize our regulatory approach.
Key Responsibilities
- Support the Regulatory Lead(s) to ensure the most advanced...
-
The Medical Affairs Hematology Oncology Clinical Nurse Educator, Medical Affairs is responsible for the identification and...
-
The Medical Affairs Hematology Oncology Clinical Nurse Educator, Medical Affairs is responsible for the identification and...
-
The Senior Regional Director, Field Based Medical Affairs is responsible for leading, developing, and managing a high-performing team of Medical Science Liaisons supporting the company’s solid tumor portfolio, with a primary focus on endometrial cancer as well as being an integral part of the GMSA LT. The Senior Director is responsible for cultivating, implementing, and managing scientific expertise and knowledge to ensure successful communication, education, and implementation of Karyopharm’s marketed and emerging product portfolio.
The...
-
The Nurse Liaison role (KNL) is a field-based position comprised of nurses reporting to the Head of Sales. The KNL partners with their commercial team members, sales, marketing, managed markets, patient advocacy, as well as medical counterparts, and medical affairs. The KNL will be responsible for establishing strategic relationships with key customers, local and regional advocacy organizations and the oncology nursing community. This collaborative approach will serve to provide education, enhanced clinical care, and the opportunity to build strategic relationships with both key customers and Karyopharm internal customers. The KNL educates and trains clinical...
-
R
The Director of Medical Communications will be a member of Global Medical and Scientific Affairs...
-
TheThe Director, Global Publications Lead
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
The Executive Director, Brand Lead – Endometrial Cancer (EC) is a senior commercial leader responsible for U.S. brand strategy, launch readiness, performance planning, and lifecycle management for Karyopharm’s EC program. This is a unique opportunity to shape the U.S. commercial strategy for a potential new treatment approach in endometrial cancer at a pivotal moment for Karyopharm. The Brand Lead will help translate late-stage science into a launch-ready commercial strategy, build the market with urgency and discipline, and lead cross-functional efforts focused on improving outcomes for patients with advanced or recurrent endometrial cancer.
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
RThe Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The MSL
-
The Medical Science Liaison (MSL), Solid Tumors serves as Karyopharm’s field-based scientific expert supporting the company’s endometrial cancer program and broader solid tumor strategy. The...
-
The Corporate Account Director (CAD) will play a critical role in ensuring that Karyopharm and its products are well positioned for extensive customer/patient access at launch and ongoing revenue target achievement and growth within the assigned accounts. The CAD role will be broad in scope of responsibility, account base, and internal customer partnerships. Ultimately, the CAD will enhance Karyopharm business growth by identifying strategic partnering opportunities, developing business plans to capitalize on those opportunities, and optimally executing the plans in each account. When working with the assigned accounts, the CAD will partner with multiple internal...
-
The Medical Science Liaison (MSL), Hematology serves as Karyopharm’s field-based scientific expert supporting multiple myeloma and emerging hematology programs, including potential future indications in myelofibrosis. The MSL is responsible for developing and maintaining strategic relationships with national, regional, and community-based thought leaders, investigators, healthcare professionals, and health systems. This role facilitates the compliant exchange of scientific information, gathers actionable medical insights, supports evidence...